Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester

Leukemia and Lymphoma

Volumn 47, Issue 6, 2006, Pages 1149-1150

  Suppiah, Revathi ^a   Kalaycio, Matt ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BCR ABL PROTEIN; HEMOGLOBIN; HYDROXYUREA; IMATINIB;

ADULT; ARTICLE; BASOPHIL; BLOOD SMEAR; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DRUG EXPOSURE; FEMALE; FIRST TRIMESTER PREGNANCY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HEPATOSPLENOMEGALY; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; LYMPHADENOPATHY; NEUTROPHIL COUNT; PHYSICAL EXAMINATION; PREGNANCY OUTCOME; PREGNANCY TEST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINUSITIS; THORAX PAIN; THROMBOCYTE COUNT; THROMBOCYTOSIS; VAGINAL DELIVERY;

ADULT; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; PIPERAZINES; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PYRIMIDINES; TREATMENT OUTCOME;

EID: 33746281435     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190500399029     Document Type: Article

References (13)

1. Lichtman, M and Liesveld, J.(2001) Acute myelogenous leukemia. In Williams hematology6th ed. (pp. 1047). New York: McGraw-Hill.
2. Heartin, E and Walkinshaw and Clark, R. (2004) Successful outcome of pregnancy in chronic myeloid leukemia treated with imatinib (Letter to the editor) Leuk Lymphoma, 45, pp. 1307-1308.
3. Baer, M and Ozer, H and Foon, K. (1992) Interferon alpha therapy during pregnancy in chronic myelogenous leukemia and hairy cell leukemia B J Haematol, 81, pp. 167-169.
4. Delmer, A and Rio, B and Bauduer, F and Ajchenbaum, F and Marie, J and Zittoun, R. (1992) Pregnancy during myelosuppressive treatment for chronic myelogenous leukaemia [letter] B J Haematol, 82, pp. 783-784.
5. Patel, M and Dukes, I and Hull, J. (1991) Use of hydroxyurea in chronic myeloid leukemia during pregnancy: A case report Am J Obstetrics Gynecol, 165, pp. 565-566.
6. Jackson, N and Shukri, A and Ali, K. (1993) Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy B J Haematol, 85, pp. 203-204.
7. Tertian, G and Tchernia, G and Papiernik, E and Elefant, E. (1992) Hydroxyurea and pregnancy [letter] Am J Obstetrics Gynecol, 166, pp. 1868.
8. Fitzgerald, J and McCann, S. (1993) The combination of hydroxyurea and leukapheresis in the treatment of chronic myeloid leukemia in pregnancy Clin Lab Haematol, 15, pp. 63-65.
9. Reichel, R and Linkesch, W and Schetitska, D. (1992) Therapy with recombinant interferon alpha-2c during unexpected pregnancy in a patient with chronic myeloid leukemia B J Haematol, 82, pp. 472.
10. Fitzgerald, D and Rowe, J and Heal, J. (1986) Leukapheresis for control of chronic myelogenous leukemia during pregnancy Am J Hematol, 22, pp. 213-218.
11. Strobl, F and Boelkerding, K and Smith, E. (1999) Management of chronic myeloid leukemia during pregnancy with leukapheresis J Clin Apheresis, 14, pp. 42-44.
12. Hensley, M and Ford, J. (2003) Imatinib treatment: Specific issues related to safety, fertility, and pregnancy Sem Hematol, 40, pp. 21-25.
13. Novartis Pharmaceuticals Corporation.(2001) Gleevec (imatinib mesylate) package insert. East Hanover NJ: Novartis Pharmaceuticals Corporation.